Trovagene (TROV) Misses Q1 EPS by 8c

Trovagene (NASDAQ: TROV) reported Q1 EPS of ($0.32), $0.08 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Trovagene (TROV) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch